Dec 19 (Reuters) - BioMarin Pharmaceutical (BMRN) said on Friday it would acquire Amicus Therapeutics (FOLD) for about $4.8 billion, expanding its presence in rare metabolic diseases.
The drugmaker will pay $14.50 per share for Amicus, a premium of 33.1% to the stock's last close. Shares of Amicus surged 30%, while BioMarin rose nearly 5% in premarket trading.
The deal strengthens BioMarin's portfolio with Amicus' approved genetic disorder treatments including Galafold, an oral drug for Fabry disease, which is caused by a faulty gene that leads to a buildup of fatty substances in cells.
Amicus also markets a combination therapy Pombiliti and Opfolda for Pompe disease, a genetic condition in which a complex sugar called glycogen builds up in the body's cells.
Amicus also has U.S. rights to DMX-200, a potential treatment of a type of kidney disease known as focal segmental glomerulosclerosis.
BioMarin intends to finance the deal through a combination of cash on hand and about $3.7 billion of non-convertible debt financing.
The company's total cash and investments at the end of September 30 were about $2 billion.
The acquisition, which is expected to close in the second quarter of 2026, will add revenue immediately after the transaction closes, BioMarin said.
The deal is also expected to add to adjusted profit in the first 12 months after close and be substantially accretive beginning in 2027, the company said.
(Reporting by Christy Santhosh and Sriparna Roy in Bengaluru; Editing by Leroy Leo and Maju Samuel)
latest_posts
- 1
Parents who delay baby's first vaccines also likely to skip measles shots - 2The Most Vital Crossroads in Olympic History
- 3Investigate Something else for Less: Financial plan Travel Objections
- 4Figure out how to Consolidate All encompassing Practices with a Degree in Brain research
- 5Make your choice for the bird that catches your heart!
- World’s tallest bridge and biggest museum named ‘greatest places of 2026’
- Soldiers seize power in Guinea-Bissau and detain the president
- Scientists document a death from a meat allergy tied to certain ticks
- 'Women on the floor, riddled with bullets': Ex-hostage Rom Braslavski recounts 'horrors' of Oct. 7
- NI economy losing momentum due to Iran crisis
- Voting begins in Uganda’s presidential election during internet shutdown and polling station delays
- Germany and trade unions kick off tough public-sector wage talks
- Bronze Age "City of Seven Ravines" unearthed in central Asia after 3,500 years
- The Specialty of Cleaning up: Change Your Space and Brain
